Sperm vs COVID-19: an unexpected case of male infertility
DOI:
https://doi.org/10.32385/rpmgf.v41i3.14149Keywords:
Azoospermia, COVID-19, Infertility, SARS-CoV-2Abstract
Introduction: Azoospermia is defined by the complete absence of spermatozoa in the ejaculate, resulting in the impossibility of conceiving with the male partner’s sperm. It is one of the most impactful forms of male infertility for couples. An increase in infertility cases reported after SARS-CoV-2 infection suggests a potential correlation between the virus and impaired spermatogenesis. Case description: A 42-year-old male, living with his wife and daughter, had a SARS-CoV-2 infection in 2022. He had no relevant past medical history or regular medication use. In January 2024, he consulted his family doctor (FD) due to secondary infertility, after 14 months of unsuccessful attempts to conceive, despite normal fertility studies in his wife. A spermogram revealed a complete absence of sperm and immature germ cells. A second analysis at a specialized clinic in March 2024 confirmed azoospermia. He was referred to urology, where further hormonal and ultrasound evaluations in May 2024 showed normal results. A testicular biopsy was suggested but refused by the patient. The couple decided not to pursue additional investigations or assisted reproduction techniques. At the follow-up appointment in July 2024, the FD offered psychological support due to the diagnosis’s potential emotional and social impact. Comment: Considering the patient's clinical history and current literature, SARS-CoV-2 infection appears to be the most plausible cause of his azoospermia. Although the couple has come to terms with the diagnosis, it remains a life-altering condition. This case highlights the critical role of the FD in providing not only clinical guidance but also emotional and psychological support and alternative options tailored to the couple’s preferences and needs. Introduction: Azoospermia is a medical condition defined by the total absence of spermatozoids in the sperm and by the impossibility of conceiving a pregnancy with those spermatozoids, being the type of infertility that affects the couple the most. Because of the increase in infertility cases described after SARS-CoV-2 infection, there seems to be a correlation between infertility and this type of infection.Downloads
References
1. Chen J, Chen J, Fang Y, Shen Q, Zhao K, Liu C, et al. Microbiology and immune mechanisms associated with male infertility. Front Immunol. 2023;14:1139450.
2. He J, Zhao Y, Zhou Z, Zhang M. Machine learning and integrative analysis identify the common pathogenesis of azoospermia complicated with COVID-19. Front Immunol. 2023;14:1114870.
3. Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2-10.
4. Fainberg J, Kashanian JA. Recent advances in understanding and managing male infertility. F1000Res. 2019 May 16;8:F1000 Faculty Rev-670.
5. Rouchou B. Consequences of infertility in developing countries. Perspect Public Health. 2013;133(3):174-9.
6. Cioppi F, Rosta V, Krausz C. Genetics of azoospermia. Int J Mol Sci. 2021;22(6):3264.
7. Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):15-26.
8. Gharagozloo P, Cartagena S, Moazamian A, Drevet JR, Somkuti S, Aitken RJ. Rapid impact of COVID-19 infection on semen quality: a case report. Transl Androl Urol. 2022;11(1):110-5.
9. Morselli S, Sebastianelli A, Liaci A, Zaccaro C, Pecoraro A, Nicoletti R, et al. Male reproductive system inflammation after healing from coronavirus disease 2019. Andrology. 2022;10(6):1030-7.
10. Paira DA, Beltramone F, Olmedo JJ, Tissera AD, Molina RI, Fux-Otta C, et al. Persistent oligonecrozoospermia after asymptomatic SARS-CoV-2 infection: a case report and literature review. Heliyon. 2023;9(9):e20340.
11. Gacci M, Coppi M, Baldi E, Sebastianelli A, Zaccaro C, Morselli S, et al. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum Reprod. 2021;36(6):1520-9.
12. Kalfas T, Kaltsas A, Symeonidis EN, Symeonidis A, Zikopoulos A, Moustakli E, et al. COVID-19 and male infertility: is there a role for antioxidants? Antioxidants (Basel). 2023;12(8):1483.
13. Kordzadeh A, Liu MO, Jayanthi NV. Male infertility following inguinal hernia repair: a systematic review and pooled analysis. Hernia. 2017;21(1):1-7.
14. Hallén M, Westerdahl J, Nordin P, Gunnarsson U, Sandblom G. Mesh hernia repair and male infertility: a retrospective register study. Surgery. 2012;151(1):94-8.
15. Damous SH, Damous LL, Borges VA, Fontella AK, Miranda JD, Koike MK, et al. Bilateral inguinal hernia repair and male fertility: a randomized clinical trial comparing Lichtenstein versus laparoscopic transabdominal preperitoneal (TAPP) technique. Surg Endosc. 2023;37(12):9263-74.
16. Diaz P, Dullea A, Patel M, Blachman-Braun R, Reddy R, Khodamoradi K, et al. Long-term evaluation of sperm parameters after coronavirus disease 2019 messenger ribonucleic acid vaccination. F S Rep. 2022;3(3):211-3.
17. Zaçe D, La Gatta E, Petrella L, Di Pietro ML. The impact of COVID-19 vaccines on fertility: a systematic review and meta-analysis. Vaccine. 2022;40(42):6023-34.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Portuguese Journal of Family Medicine and General Practice

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.